The impact of molecular manipulation in residue 114 of human immunodeficiency virus type-1 reverse transcriptase on dNTP substrate binding and viral replication. 2012

Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.

Human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) has a unique tight binding to dNTP substrates. Structural modeling of Ala-114 of HIV-1 RT suggests that longer side chains at this residue can reduce the space normally occupied by the sugar moiety of an incoming dNTP. Indeed, mutations at Ala-114 decrease the ability of RT to synthesize DNA at low dNTP concentrations and reduce the dNTP-binding affinity (K(d)) of RT. However, the K(d) values of WT and A114C RT remained equivalent with an acyclic dNTP substrate. Finally, mutant A114 RT HIV-1 vectors displayed a greatly reduced transduction in nondividing human lung fibroblasts (HLFs), while WT HIV-1 vector efficiently transduced both dividing and nondividing HLFs. Together these data support that the A114 residue of HIV-1 RT plays a key mechanistic role in the dNTP binding of HIV-1 RT and the unique viral infectivity of target cell types with low dNTP pools.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015967 Gene Expression Regulation, Viral Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses. Regulation of Gene Expression, Viral,Viral Gene Expression Regulation,Regulation, Gene Expression, Viral

Related Publications

Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
April 2004, Biochemistry,
Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
July 1991, Proceedings of the National Academy of Sciences of the United States of America,
Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
October 2006, The Journal of biological chemistry,
Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
December 1994, Proceedings of the National Academy of Sciences of the United States of America,
Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
November 2003, Antimicrobial agents and chemotherapy,
Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
February 1996, Biological chemistry Hoppe-Seyler,
Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
May 1994, Virology,
Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
August 1993, Antimicrobial agents and chemotherapy,
Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
May 2006, The Journal of biological chemistry,
Sarah K Van Cor-Hosmer, and Waaqo Daddacha, and Z Kelly, and Amy Tsurumi, and Edward M Kennedy, and Baek Kim
June 1996, Uirusu,
Copied contents to your clipboard!